Results of a small clinical trial showing the benefits of a new pill to treat high blood pressure have been published today.
The study, conducted by The George Institute for Global Health and published in The Lancet, found that patients given the new four-treatments-in-one pill saw their blood pressure drop to normal levels in just four weeks.
A risk factor
Nearly 30 per cent of adults in the UK are living with high blood pressure, putting them at risk of having a heart attack or stroke.
Experts have called the results exciting, but suggest larger trials are needed to see if these high rates could be maintained and repeated.
What we said
Our Associate Medical Director, Professor Metin Avkiran, commented on the study.
“High blood pressure is a major risk factor for strokes and heart attacks. The British Heart Foundation estimates that nearly 30 per cent of adults in the UK are living with high blood pressure, putting them at risk of having a heart attack or stroke.
“The quadpill used in this study combined four existing blood pressure-lowering drugs at low dose in one pill, to reduce blood pressure. Although the findings are encouraging and may lead to effective treatments without side effects, the study involved only a small number of patients for a short period. More research is needed to confirm the safety of the quadpill, its long-term effect on blood pressure and ultimately whether it reduces a person’s risk of having a stroke or heart attack, before it should be considered in clinic.
“Since the majority of people with high blood pressure have no symptoms, a big part of the battle is identifying who has it and ensuring that patients continue to take their prescribed medication. If you are concerned about your blood pressure we recommend speaking to your GP.”